Health ❯ Healthcare ❯ Diabetes

Insulin Therapy

Inhaled Insulin Weekly Insulin Shots Non-Insulin Therapies Awiqli Clinical Trials Insulin Patch Pump Afrezza Weekly Insulin Patient Management Icodec Once-Weekly Insulin

4 ARTICLES

2mo ago

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

The move pauses development of a once‑daily GLP‑1/GIP dual agonist after a 16‑week trial showed A1C reductions, meaningful weight loss, and lower insulin needs.

7 ARTICLES

2mo ago

FDA Expands Afrezza Inhaled Insulin Approval to Children Ages 6 and Up

3 ARTICLES

7mo ago

Insulin Therapy

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

FDA Expands Afrezza Inhaled Insulin Approval to Children Ages 6 and Up

ViCentra Adds $13 Million to Series D, Lifting Kaleido Funding to $98 Million